[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552247":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":15,"responsibleParty":31,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":18,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Scientific Institute San Raffaele","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Pierluigi Novellis, MD","CONTACT","+39022643","7202","novellis.pierluigi@hsr.it",[16],{"facility":17,"status":18,"city":19,"state":7,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Scientific Institute Ospedale San Raffaele","RECRUITING","Milan","20132","Italy","IT",{"type":24,"coordinates":25},"Point",[26,27],9.18951,45.46427,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":7},{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Pierluigi Novellis","MD","100552247","the-lymphocytic-infiltrate-of-lung-tumors-100552247",false,"NCT06470607","The Lymphocytic Infiltrate of Lung Tumors.","Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors","TREGILC","Inclusion Criteria:\n\n* Ability to provide informed consent;\n* Men and women over the age of 18;\n* Patients candidates for surgical treatment diagnosed with thoracic tumors\n\nExclusion Criteria:\n\n* Previous chemotherapy for any cancer within the last 6 months;\n* Pregnant and\u002For breastfeeding women;\n* Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive\u002Fimmunomodulatory treatments)","ALL","18 Years",{"count":46,"type":47},70,"ESTIMATED","OBSERVATIONAL","The study is configured as a monocentric observational transversal biological study.\n\nThe main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC).\n\nThe study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.",[51,52],"Lung Cancer","Immune System",[54,55,56],"thoracic tumors","Immune checkpoints","lymphocytes","2024-11-26",{"date":59,"type":60},"2024-11-29","ACTUAL",{"date":62,"type":60},"2023-01-20",{"date":64,"type":47},"2028-01-31",{"name":5,"class":6},1]